NCT05557123 is a NA clinical trial of MEDI-app in Atrial Fibrillation, sponsored by Seoul National University Bundang Hospital.

Who is sponsoring NCT05557123?

NCT05557123 is sponsored by Seoul National University Bundang Hospital.

What drugs are being tested in NCT05557123?

Interventions in NCT05557123: MEDI-app.

What condition does NCT05557123 study?

NCT05557123 studies Atrial Fibrillation.

Is NCT05557123 still recruiting?

NCT05557123 is currently recruiting now. Last updated 28 January 2025.

Last reviewed 2025-01-28 · How we verify

NCT05557123

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile App for Improving Adherence of Rivoxaban (RIVOX-AF)

Recruiting now NA Last updated 28 January 2025

What this trial tests

NA trial testing MEDI-app in Atrial Fibrillation in 1,042 participants. Currently enrolling.

Timeline

10 March 2022

Primary endpoint
30 June 2025

31 December 2025

Quick facts

Lead sponsor	Seoul National University Bundang Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,042
Start date	10 March 2022
Primary completion	30 June 2025
Estimated completion	31 December 2025
Sites	1 location across South Korea

Drugs / interventions tested

MEDI-app

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Seoul National University Bundang Hospital

Who can join

19 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

RIVOX-AF study is a prospective, multicenter, randomized controlled study in which patients with AF are allocated to medication-app group or conventional treatment group. The App based feed-back algorithm will provide the patients with check taking drug or reminding of taking drug.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The ReInforcement of adherence via self-monitoring app orchestrating biosignals and medication of RivaroXaban in patients with atrial fibrillation and co-morbidities: a study protocol for a randomized controlled trial (RIVOX-AF).
Yoon M, Park JJ, Hur T, Hua CH, et al · · 2023 · cited 2× · PMID 37324622 · DOI 10.3389/fcvm.2023.1130216

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

NCT07459725 — Comparison of EEG-Timed vs. Repetitive Robot Therapy for Chronic Stroke · NA · not yet recruiting
NCT07455279 — Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study · not yet recruiting
NCT07477574 — Muscle-Specific Multimodal AI for Sarcopenia Diagnosis · NA · not yet recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07305662 — Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGU · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05557123 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Bundang Hospital
Last refreshed: 28 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05557123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing